Eli Lilly (LLY) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 
Eli Lilly And Company  (NYSE: LLY)
 

Eli Lilly Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Eli Lilly And's inventory turnover ratio sequentially decreased to 0.92 in the second quarter 2026, unsurprisingly, as the Eli Lilly And markets continue to deteriorate, and LLY's faces growing challenges to bring down its inventories. Eli Lilly And's average inventory processing period in the Jun 30 2026 quarter, has increased to 397 days, from 380 days, in the Mar 31 2026 quarter.

Within Healthcare sector 322 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 452 in the first quarter 2026, to 1847.

LLY Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Eli Lilly And Company Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LLY Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth 52.47 % 56.04 % 81.1 % 63.28 % 69.93 %
Y / Y Cost of Sales Growth 33.51 % 60.82 % 40.27 % 38.58 % 12.79 %
Inventory Turnover Ratio (TTM) 0.92 0.96 0.96 1.01 1.05
LLY's Total Ranking # 1847 # 452 # 419 # 446 # 1074
Average inventory processing period 395 379 382 363 349
Seq. Inventory Growth 15.58 % 5.71 % 12.84 % 10.59 % 18.29 %
Seq. Cost of Sales Growth -8.64 % 6.09 % 12.08 % 22.9 % 10.05 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 96
Healthcare Sector # 323
Overall Market # 1847

Inventory Turnover Ratio Statistics
High Average Low
2.09 1.57 0.92
(June 30. 2012)   (Jun 30 2026)



LLY Company Profile >> Back to LLY Efficiency Comparisons >> Compare LLY Inventory Turnover Ratio to its Competitors

Financial Statements
Eli Lilly And's Inventories $ 16,793 Millions Visit LLY's Balance sheet
Eli Lilly And's Cost of Revenues TTM $ 13,225 Millions Visit LLY's Income Statement
What are LLY's Sales? Visit LLY's Sales by Segment

Other Inventory Turnover Ratios
Eli Lilly And's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
LLY's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for LLY's Competitors
Inventory Turnover Ratio for LLY's Suppliers
Inventory Turnover Ratio for LLY's Customers

You may also want to know
LLY's Sales Growth Rates LLY's Pe Price to earnings ratio LLY's Receivables Turnover Ratio LLY's Stock Quote
LLY's Net Income Growth Rates LLY's Ps Price to Sales ratio LLY's Sales per Employee LLY's Asset Turnover Ratio
LLY's Net Margin LLY's Pb Price to Book ratio LLY's Financial Strength Ratios LLY's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Johnson and Johnson  2.17 $ 31,428.000  Millions$ 14,516  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  2.15 $ 14.508  Millions$ 7  Millions
Orthofix Medical Inc   2.15 $ 240.218  Millions$ 112  Millions
Icu Medical Inc  2.15 $ 1,314.853  Millions$ 613  Millions
Anika Therapeutics Inc   2.14 $ 46.366  Millions$ 22  Millions
Amphastar Pharmaceuticals Inc   2.14 $ 381.911  Millions$ 178  Millions
Bioventus Inc   2.14 $ 182.542  Millions$ 85  Millions
Dariohealth Corp   2.10 $ 8.985  Millions$ 4  Millions
Bio techne Corp  2.10 $ 414.798  Millions$ 197  Millions
Yunhong Green Cti Ltd   2.09 $ 17.362  Millions$ 8  Millions
Aytu Biopharma Inc  2.09 $ 18.697  Millions$ 9  Millions
Repligen Corp  2.08 $ 362.434  Millions$ 174  Millions
Anteris Technologies Global Corp   2.08 $ 0.561  Millions$ 0  Millions
Lifevantage Corp  2.08 $ 39.334  Millions$ 19  Millions
Boston Scientific Corporation  2.07 $ 6,315.000  Millions$ 3,054  Millions
Organon and Co   2.06 $ 2,899.000  Millions$ 1,405  Millions
Glaukos Corp  2.06 $ 128.016  Millions$ 62  Millions
Orasure Technologies Inc  2.05 $ 64.117  Millions$ 31  Millions
Zomedica Corp   2.05 $ 11.772  Millions$ 6  Millions
Phibro Animal Health Corporation  2.02 $ 1,004.346  Millions$ 498  Millions
Waters Corporation  2.00 $ 2,008.498  Millions$ 1,005  Millions
Clearpoint Neuro Inc   1.96 $ 15.809  Millions$ 8  Millions
Skinhealth Systems Inc   1.95 $ 96.775  Millions$ 50  Millions
Retractable Technologies Inc  1.94 $ 33.979  Millions$ 17  Millions
Intuitive Surgical Inc   1.94 $ 3,676.900  Millions$ 1,899  Millions
Lifeloc Technologies Inc   1.93 $ 5.381  Millions$ 3  Millions
Accuray Incorporated  1.93 $ 290.064  Millions$ 150  Millions
Nature s Sunshine Products inc   1.92 $ 131.811  Millions$ 69  Millions
Insulet Corporation  1.91 $ 883.000  Millions$ 462  Millions
Cytek Biosciences Inc   1.90 $ 96.247  Millions$ 51  Millions

Date modified: 2026-09-12T18:39:21+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.